Details for Patent: 12,414,915
Which drugs does patent 12,414,915 protect, and when does it expire?
Patent 12,414,915 protects KLOXXADO and is included in one NDA.
This patent has fourteen patent family members in seven countries.
Summary for Patent: 12,414,915
| Title: | Liquid naloxone spray |
| Abstract: | The invention provides stable liquid formulations containing naloxone, a pharmaceutically acceptable salt or a derivative thereof. The invention further provides methods for treating opioid overdose, opioid dependence, and congenital insensitivity to pain with anhidrosis by administering the liquid formulations of the present invention intranasally to a patient in need thereof. Further, the invention provides a method of treating opioid dependence, opioid overdose, and congenital insensitivity to pain with anhidrosis by administering intranasally the naloxone formulations of the present invention. |
| Inventor(s): | Kiran Amancha, Chandeshwari Chilampalli, Thrimoorthy Potta, Ningxin Yan, Venkat R. Goskonda |
| Assignee: | Hikma Pharmaceuticals USA Inc |
| Application Number: | US18/109,561 |
|
Patent Claim Types: see list of patent claims | Formulation; Compound; |
Drugs Protected by US Patent 12,414,915
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hikma | KLOXXADO | naloxone hydrochloride | SPRAY;NASAL | 212045-001 | Apr 29, 2021 | RX | Yes | Yes | 12,414,915 | ⤷ Start Trial | Y | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 12,414,915
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2017312811 | ⤷ Start Trial | |||
| Canada | 2954370 | ⤷ Start Trial | |||
| Canada | 3033897 | ⤷ Start Trial | |||
| China | 109922805 | ⤷ Start Trial | |||
| European Patent Office | 3177146 | ⤷ Start Trial | |||
| European Patent Office | 3500261 | ⤷ Start Trial | |||
| Japan | 2017519803 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
